Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 1Neuroendocrine Tumors 1Glioma 1Carcinoma, Medullary 1Brain Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Sorafenib 5Everolimus 3vandetanib 2selpercatinib 2lutetium Lu 177 dotatate 2cabozantinib 2Sunitinib 2yeast-CEA vaccine 1tanespimycin 1sargramostim 1ponatinib 1pembrolizumab 1pazopanib 1pasireotide 1nintedanib 1motesanib diphosphate 1lenvatinib 1cemiplimab 1aldesleukin 1Vorinostat 1Thalidomide 1Temozolomide 1Tamoxifen 1Radiotherapy 1Pharmacogenomic Testing 1Octreotide 1Melphalan 1Lithium Carbonate 1Irinotecan 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Medullary × Lithium Carbonate × Clear all
NCT00582712 2019-12-09

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 7 charts

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡